- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Sharon Phares Lists the Many Factors Physicians Should Consider When Choosing Therapies
Sharon Phares, PhD, MPH, chief scientific officer of the National Pharmaceutical Council, explained the importance of taking multiple factors into consideration when making health care decisions.
Sharon Phares, PhD, MPH, chief scientific officer of the National Pharmaceutical Council, explained the importance of taking other factors in addition to gender into consideration when making health care decisions, marking Women's Health Month.
Transcript
How well do health technology assessments currently take into account gender differences? How can it be done better?
Currently, gender differences are not looked at very often only when they are specific to a therapy. So, for instance, if you're looking at a therapy for breast cancer, although men can get breast cancer, they're less likely to. But how they could do it differently is to really look at differences by groups. Do women get impacted the same as men and is the value the same? Similarly, it can be said for other groups, not just men and women, but also people of color, people of different ethnicities, etc, to kind of look at those combinations of gender and racial or cultural identity, as well as some issues around things like socioeconomic status, which can impact the value, so to speak, of a medication for a certain group.
Understanding TB Symptoms, Spread, Treatment Amid Kansas City Outbreak
February 13th 2025In part 2 of this interview, Michael A. Bernstein, MD, highlights the need for prolonged antibiotics and strong public health measures to combat tuberculosis (TB) at both the individual and population levels.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Evolent’s Wonsettler Sees Outcomes-Based Reimbursement as “A Healthy Tool”
February 7th 2025Terra Wonsettler, PharmD, MBA, vice president of pharmacy for Evolent, discusses the recent HHS OIG report that stemmed from the 2021 FDA approval of aducanumab (Aduhelm) and use of the accelerated approval pathway.
Read More
